The Rapid Strep system (API System S.A., Montalieu-Vercieu, France) was evaluated, without additional tests, in the identification of 209 streptococci. Organisms included 59 beta-hemolytic, 36 group D, 24 Streptococcus pneumoniae, and 90 viridans group streptococci. The Rapid Strep system correctly identified to species level 69.5% of the beta-hemolytic strains, 100% of the group D strains, none of the S. pneumoniae strains, and 84.5% of the viridans group streptococci. The method provided excellent identification rates of groups A, B, and D but failed to differentiate between groups C and G. The method for preparation of suspensions for the Rapid Strep system, as initially recommended by the manufacturer, was responsible for the failure to identify S. pneumoniae. This method was subsequently modified to yield a heavier inoculum; all 10 pneumococcal strains tested with the revised inoculum method were correctly identified. Good identification rates of commonly encountered viridans strains were found. The Rapid Strep system represents a worthwhile advance in streptococcal species identification, especially for group D and viridans strains.
Streptococci comprise a large portion of gram-positive cocci isolated and identified in clinical microbiology laboratories. Although many of these organisms (e.g., groupable beta-hemolytic strains and pneumococci) can be presumptively or definitively identified by relatively simple and rapid tests, this is not the case for species identification of the group D and viridans group streptococci, which require time-consuming conventional tests for accurate species identification (4, 5) . Although enterococcal and non-enterococcal group D strains can be differentiated with the aid of relatively simple tests, accurate species identification of enterococcal and non-enterococcal group D organisms requires additional testing (5) . Species identification of group D and viridans group streptococci is important clinically and epidemiologically and will help delineate the spectrum of disease caused by particular species (1).
Commercial methods which have been developed for the identification of streptococci include the API 20S system (1, 6, 7) (Analytab Products, Inc., Plainview, N.Y.), API ZYM (12) (API Laboratory Products, Farnborough, United Kingdom), and the Gram-Positive Identification Card (1, 8) (Vitek Systems, Inc., Hazelwood, Mo.). All of these systems are fairly inaccurate in the identification of viridans group streptococci and display various degrees of accuracy in the identification of other streptococcal groups (1, [6] [7] [8] 12) .
Microbiology laboratories without facilities for extended conventional testing require an accurate and reliable method for streptococcal species identification. The aim of the current study was to evaluate the capability of the Rapid Strep system (API System S.A., Montalieu-Vercieu, France) to accurately identify a spectrum of clinically significant streptococci without the aid of additional tests. Previous reports have noted excellent agreement between results obtained with a prototype of this system and those obtained by conventional methods (11) ; good identification rates of viridans group streptococci have also been reported with this technique (9 2 S. faecium ribose-negative, 3 S. salivarius; 2 LD: S. pneumoniae) and 10 doubtful identifications. Of the 10 doubtful profiles, 6 (groups C and G; S. MG-intermedius), included the correct identification in a range of two or more possibilities; the remaining 4 (all S. pneumoniae) yielded incorrect results.
Misidentifications by the Rapid Strep system are shown in Table 2 . A total of 12 S. pneumoniae strains were misidentified as S. sanguis II, and 1 was misidentified as S. salivarius-S. bovis II. Three S. mitis strains were misidentified as S. sanguis I. Two S. sanguis I strains were misidentified, one as S. salivarius-S. bovis II, the other as S. sanguis II. One S. MG-intermedius strain was misidentified as S. sanguis I, one S. mutans as S. milleri, and one S. anginosus-constellatus as S. pneumoniae-S. sanguis II. DISCUSSION Identification rates of beta-hemolytic and group D organisms by the Rapid Strep system are comparable to those reported with other systems (1, 6-8); excellent identification rates of groups A, B, and D were observed, but serogrouping was necessary to differentiate between groups C and G. Unsatisfactory results with S. pneumoniae may be explained by insufficient inocula, leading to negative key sugar reactions. After completion of the study, we were informed by the manufacturer that inocula of S. pneumoniae should be prepared from two blood agar plates incubated anaerobically. In our experiment, inocula from one plate incubated under CO2 yielded sufficiently turbid inocula, equivalent to those used for organisms yielding correct identifications. Retesting of 10 pneumococcal strains with the modified inoculum preparation technique yielded correct results in every case. Since the Rapid Strep system is only likely to be used for exceptional pneumococcal isolates that do not have the typical morphology of S. pneumoniae, use of the heavier inoculum may be advisable for all isolates that the system identifies as S. sanguis II (see Table 2 ). Results of testing viridans group streptococci in our study were similar to those obtained by Ruoff and Kunz (9) . If additional tests would have been performed for LD profiles, correct species identification rates would have reached 90.0%, a rate higher than those reported for the API 20S system (1, 7), the GramPositive Identification Card (1, 8) , and the API ZYM (12) , all of which are below 75%. The Rapid Strep system is relatively easy to use and easy to interpret. Improvement in the packaging of Voges-Proskauer and enzyme reagents would facilitate the use of the product.
The Rapid Strep system permits identification of biotypes within species of S. pyogenes, S. faecalis, S. faecium, S. durans, S. bovis II, S. mitis, S. milleri, S. sanguis I, S. sanguis II, and S. pneumoniae. No attempt was made in the current study to correlate these biotypes with those obtained by conventional testing. The three S. mitis strains (arginine dihydrolase positive) misidentified as S. sanguis I (biotype 3) correspond to arginine dihydrolase-positive S. mitis and to dextran-positive S. mitior (S. mitis) described by Colman and Williams (3); this may be more a taxonomic discrepancy than a misidentification. In the Rapid Strep system, European rather than U.S. nomenclature is used in the identification of S. MG-intermedius and S. anginosus-constellatus; S. milleri biotype 1 corresponds to beta-hemolytic S. milleri (including some group F strains), biotype 2 includes strains designated either as S. MG-intermedius or as S. anginosusconstellatus in the scheme of Facklam (4) , and S. milleri biotype 3 corresponds to S. milleri strains described by Ball and Parker (2) and referred to as unidentified urine isolates in previous studies (9) . In the current study, all correctly identified S. MG-intermedius strains were identified as either S. milleri biotype 1 (beta-hemolytic) or biotype 2. Identification of group F (currently not included as such in the database) as S. milleri biotype 1 (beta-hemolytic) has been described previously (2) . Although S. morbillorum is currently not included in the code book, the one strain tested was correctly identified by the extended database.
A shortcoming of the Rapid Strep system as currently available is the lack of a computerized back-up service for numbers not present in the code book. At present an incomplete database is available in the United States, and problems must be referred by telex to the parent company in France. Five beta-hemolytic strains with doubtful profiles yielded typical reactions, with the exception of negative ribose tests. Additionally, two correctly identified ribosenegative S. faecium strains yielded profiles not present in the current code book. A locally available computerized service which could provide rapid information on such biochemically atypical strains would improve the accuracy of the product. Although the Rapid Strep system enables the identification of most beta-hemolytic and group D strains after 4 h, overnight incubation is required for S. pneumoniae and viridans group streptococci. The additional incubation period improves the accuracy of the system and is still shorter than those required by simplified conventional schemes (5, 10) .
The advantage of the Rapid Strep system for the identification of beta-hemolytic streptococci is questionable, since convenient, rapid methods already exist for identification of these strains. The failure of the system with the initial inoculum method to identify S. pneumoniae is unlikely to detract from its usefulness, since the vast majority of pneumococci will be identified on the basis of colony morphology, bile solubility, and optochin susceptibility.
In summary, the principal potential of the Rapid Strep system is in species identification of group D and viridans group streptococci. The system yields excellent identification of group D strains and good identification of viridans group streptococci. The system would be further improved by revisions in taxonomy and enlargement of the database.
